Chinese Medical Industry News

14 July 1996

The total value of medical industry production in China last year was 100 billion renminbi ($12 billion), reports the Beijing Review. China is currently administering a project to improve the scientific and technological level of pharmaceuticals, including new studies on the development of new drugs. It is also focusing on the development of traditional Chinese medicines, a key state project.

- China's State Statistical Bureau has reported that the country exported 136,774 tones of medicinal materials in 1995, notes China Foreign Trade. The month with the highest exports last year was December, with 16,866 tons.

- Five drugs now on the Chinese market have been developed by domestic manufacturers using genetic engineering techniques, reports the Beijing Review. Over 10 medicines and vaccines are at an experimental stage. Chinese scientists are reported to be having particular success in developing drugs against various cancers.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight